SANTA CLARA, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
Initial FIH procedures launch FastWave's multi-center feasibility study evaluating the safety and performance of its laser-based coronary IVL platform. MINNEAPOLIS, June 3, 2025 /PRNewswire/ -- ...
SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Patients suffering from peripheral artery disease (PAD) are increasingly being offered a treatment by doctors called intravascular lithotripsy (IVL). Developed by Shockwave Medical, part of Johnson & ...
WASHINGTON--(BUSINESS WIRE)--Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced positive six-month data from the PINNACLE I study evaluating the ...
HACKENSACK, N.J. (CBSNewYork)-- One of the most common heart procedures done in this country is a called a coronary angioplasty. A balloon opens up a heart artery and usually a stent is placed to keep ...
SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results